The Pharma Data

NOVEMBER 23, 2020

and RESEARCH TRIANGLE PARK, N.C. , We are confident in our future thanks to our fundamental attributes, namely our obsession with quality and innovation, the power of our brands, our entrepreneurial culture, and our bioinformatics leadership. Report available at corporateresponsibility.unither.com. SILVER SPRING, Md.

Bioinformatics 40

Bioinformatics Pharmaceutical Companies DNA Government 40

DrugBank

FEBRUARY 12, 2025

The pharmaceutical industry grapples with the persistent challenge of high attrition rates and escalating costs inherent in drug development. The journey from bench to bedside often spans over a decade, consuming billions of dollars in research and development (R&D) expenditure, with a significant probability of failure at each phase.

Cell Based Assays 52

Cell Based Assays Drugs Pharmacokinetics Disease 52

The Pharma Data

DECEMBER 27, 2020

and RESEARCH TRIANGLE PARK, N.C. , We are confident in our future thanks to our fundamental attributes, namely our obsession with quality and innovation, the power of our brands, our entrepreneurial culture, and our bioinformatics leadership. Voucher expected to be applied to the forthcoming NDA for Tyvaso DPI. SILVER SPRING, Md.

FDA 52

FDA Bioinformatics Disease Production 52

The Pharma Data

OCTOBER 27, 2020

and RESEARCH TRIANGLE PARK, N.C. , Research and development expense. The table below summarizes research and development expense by major category (dollars in millions): . Research and development projects. SILVER SPRING, Md. .

FDA 40

FDA Production Licensing Licensing 40

The Pharma Data

NOVEMBER 15, 2020

In this single target research collaboration Lead Pharma and Roche will collaborate in research activities up to the selection of a pre-clinical candidate after which Roche will be responsible for further development and global commercialization. . OSS, Netherlands , Nov. About Lead Pharma.

Small Molecule 52

Small Molecule Licensing Licensing Disease 52

The Pharma Data

DECEMBER 8, 2020

and RESEARCH TRIANGLE PARK, N.C. , We are confident in our future thanks to our fundamental attributes, namely our obsession with quality and innovation, the power of our brands, our entrepreneurial culture, and our bioinformatics leadership. SILVER SPRING, Md. Forward-looking Statements.

FDA 40

FDA Treatment Drugs FDA Approval 40

The Pharma Data

OCTOBER 21, 2020

and RESEARCH TRIANGLE PARK, N.C. , ” The research, The Impact of Inhaled Treprostinil on Patient Lung Function: Results from the INCREASE Study, was presented by Aaron Waxman , M.D., Lung Biotechnology is the first public benefit corporation subsidiary of a public biotechnology or pharmaceutical company.

Disease 40

Disease Treatment Therapies Production 40

Drug Target Review

FEBRUARY 11, 2025

The major hurdles that pharmaceutical companies face are long lead times, high costs and a low probability of success (PoS). These hurdles not only delay patient access to innovative treatments but also threaten the economic sustainability of research and development (R&D) and the advancement of medical innovation.

Drug Development 59

Drug Development Bioinformatics Drugs Small Molecule 59